Issue IndexA searchable index of tables of contents
Find An Issue
Table of contents for
September 25, 2003 Vol. 349 No. 13
- Free Full Text
Theoretically, concomitant therapy with parathyroid hormone and alendronate might be synergistic, increasing bone formation while simultaneously reducing resorption. In this study, 238 postmenopausal women with osteoporosis were randomly assigned to receive daily parathyroid hormone (1–84), alendronate, or both for 12 months. Bone mineral density increased in all groups, with no significant differences between those receiving parathyroid hormone and those receiving both drugs. Bone formation increased markedly with parathyroid hormone therapy but not with combined therapy.
- Free Full Text
Parathyroid hormone increases both bone formation and bone resorption, and combining it with an antiresorptive agent might enhance its effects on bone mineral density. Eighty-three men, 46 to 85 years of age, with low bone mineral density were randomly assigned to receive alendronate, parathyroid hormone, or both; alendronate therapy was given for 30 months, and parathyroid hormone therapy was begun at month 6. Bone mineral density at the lumbar spine and the femoral neck increased significantly more with parathyroid hormone alone than with alendronate alone or combination therapy.
- Free Full Text
- Free Full Text
In 2002, 23 patients in the United States were confirmed to have acquired the West Nile virus through the transfusion of red cells, platelets, or plasma. Most of these patients were immunocompromised or at least 70 years of age, and meningoencephalitis developed in 13 patients about 10 days after the receipt of the implicated blood product.
An otherwise healthy 51-year-old woman presents to her physician with pleuritic right posterior chest pain, without dyspnea or hemoptysis. Her temperature is 38.2°C, and her pulse is 102 beats per minute. Physical examination discloses a pleural friction rub over the posterior right hemithorax but is otherwise unremarkable. A chest radiograph is normal. She is treated with an antiinflammatory agent for presumed viral pleurisy. Three days later, she returns, reporting dyspnea. How should she be evaluated?
Recent research on epilepsy has uncovered important and clinically relevant mechanisms of generalized and localized seizures, among which are inherited abnormalities of ion channels, hippocampal sclerosis, cortical malformations, and dysfunction of glial cells. This review highlights research findings that suggest possibilities for the prevention and treatment of epilepsy.
This report reviews federal regulations regarding research misconduct and argues that accused scientists should be guaranteed more procedural safeguards during investigations of alleged misconduct. Currently, the accused researcher's institution performs the investigation, and most institutional policies do not require the presumption of innocence and do not allow scientists to see the evidence against them. Investigations into research misconduct use a low standard of proof — preponderance of evidence — which requires that the evidence point to a finding that is more likely than not.
- Free Full Text
- Free Full Text
- Free Full Text
- Free Full Text
- Free Full Text
- Free Full Text
- Free Full Text
